Ansell : Investor Meeting Presentation

ASX

Announcement

only
This announcement was authorised for release by the Board of Directors of Ansell Limited.
use		ENDS
===================================================================================
For further information:
Investors & Analysts
Australia	Anita Chow, IR	Tel: [phone]	[e-mail]
Brussels	Zubair Javeed, CFO	Tel: [phone]	[e-mail]
Media
Australia	Tim Duncan, Hintons	Tel: [phone]	[e-mail]
personal

Ansell Limited Investor Meeting Presentation

21 March 2022 - Ansell Limited (ASX:ANN), a global leader in personal protection safety solutions, is pleased to provide the enclosed presentation which will be referred to during a series of investor meetings held between 21 March 2022 and 1 April 2022.

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well-being. The world's need for better protection never stops, so Ansell is constantly researching, developing and investing to manufacture and distribute cutting edge product innovation and technology, marketed under well-known brands that customers trust.

Operating in two main business segments, Industrial and Healthcare, Ansell is the market leader that continues to grow, Foremploying over 14,000 people worldwide. With operations in North America, Latin America/Caribbean, EMEA and Asia Pacific,

customers in more than 100 countries around the world trust Ansell and its protection solutions.

Information on Ansell and its products can be found at www.ansell.com. #AnsellProtects

Ansell ® and TM are trademarks owned by Ansell Limited or one of its affiliates. © 2022 Ansell Limited. All Rights Reserved

Ansell Limited, A.C.N. 004 085 330, Level 3, 678 Victoria Street, Richmond, Victoria 3121, Australia, Tel [phone], F([phone] www.ansell.com

ersonal use only

ANSELL INVESTOR UPDATE

21 MARCH 2022

Disclaimer

The following presentation has been prepared by Ansell Limited (Ansell or the Company) for information purposes only. The information contained in this presentation is a summary only and does not purport to be complete. It should be read in conjunction with Ansell's other periodic and continuous disclosure announcements lodged with the Australian Securities Exchange, which are available at www.asx.com.au.

This presentation may contain forward looking statements or statements of opinion. These statements can be identified by the use of forward-looking terminology such as 'may', 'will', 'should', 'expect', 'intend', 'anticipate', 'estimate', 'continue', 'assume', or 'forecast' or comparable terminology. These forward looking statements are current only as at the date of this presentation.

Although Ansell believes these forward looking statements to be reasonable, they are not certain and involve unknown risks and assumptions (including many that may be outside of the control
f Ansell). No representation or warranty (express or implied) is made regarding the accuracy, completeness or reliability of the forward-looking statements or opinion or the assumptions on
onlywhich either are based. All such information is, by its nature, subject to significant uncertainties outside of the control of the company. Subject to disclosure requirements, Ansell is under no
obligation to update any forward looking statements contained in this presentation.
Ansell, its related bodies corporate and any of its or their respective officers, directors, employees, agents or advisers (Ansell Parties), do not make any representation or warranty, express or
implied, in relation to the accuracy, reliability or completeness of the information contained herein, and to the maximum extent permitted by law disclaim any responsibility and liability flowing
from the use of this information by any party. To the maximum extent permitted by law, the Ansell Parties do not accept any liability to any person, organisation or entity for any loss or damage
arising from the use of this presentation or its contents or otherwise arising in connection with it.
The information included in this presentation is not intended to be relied upon and is not investment or financial product advice. This presentation is not and should not be considered as an offer
useor recommendation with respect to the subscription for, purchase or sale of any security and neither this document, nor anything in it shall form the basis of any contract or commitment. Before
making any investment decision, you should seek appropriate financial advice, which may take into account your particular investment needs, objectives and financial circumstances. Past
performance is no guarantee of future performance. The statements in this presentation do not constitute an offer to sell, or solicitation of an offer to buy, any securities of Ansell.
ersonal	2

ersonal use only

CONTENTS

01

02

03

04

05

Growth Update

Market Update and Recent Investments

Greater Focus on Operational Excellence

Update on ESG Initiatives

Concluding Remarks

3

Beating Revenue Targets Set At Last CMD

only

SALES GROWTH ABOVE 3-5% CMD TARGET EVEN

EXCLUDING COVID-19 BENEFICARIES¹

2 Yr

CAGR

1,089

+16%

1,009

938

use

860

753

+30%

ersonal

+7%

FY20 H1

FY20 H2

FY21 H1

FY21 H2

FY22 H1

Total

COVID-19 Beneficiaries

Non COVID-19 Beneficiaries

1. COVID-19 Beneficiaries include Exam/SU and Chemical Protective Clothing

2. Growth represents FY20 H1 to FY22 H1 CAGR

STRONG GROWTH² F'22 H1 vs F20 H1

ACROSS EACH OF OUR SBUs

IGBU: +3%

Mechanical	Chemical
+2%	+5%

HGBU: +27%

Surgical	Exam/SU
+13%	+33%

Life Sciences

+28%

4